Histochemistry and Cell Biology

, Volume 149, Issue 4, pp 343–351 | Cite as

Histochemical evidence of IGF2 mRNA-binding protein 2-mediated regulation of osteoclast function and adhesive ability

  • Hongrui Liu
  • Dongfang Li
  • Shanshan Liu
  • Zhaopeng Liu
  • Minqi Li
Original Paper


Insulin-like growth factor 2 (IGF2) messenger RNA-binding proteins (IMPs) are a family of oncofetal RNA-binding proteins that play important roles in cell migration, renewal, and metabolism. IMP2 gene expression may be important in determining IGF2 levels and might, thereby, be central to bone metabolism. In our present study, IMP2-deficient mice exhibited more immature bone structures, characterized by abundant residual cartilage cores; growth plates containing more rich cartilage matrix, which was arranged irregularly; and a significantly thicker hypertrophic chondrocyte layer in the femoral metaphysis, compared with wild-type mice. These abnormalities were associated with profound effects on the size and morphology of osteoclasts. Specifically, the osteoclasts exhibited various polymorphisms, failed to form resorption lacunae, and were detached from the bone surface. Consistent with these findings, IMP2 deficiency reduced the expression of two important proteases (cathepsin K and matrix metallopeptidase 9) as well as that of C-SRC, a critical regulator of ruffled border formation in osteoclasts, indicating impaired osteoclastic activity. IMP2-deficient mice also displayed inhibited osteoclast adhesion owing to defects in the CD44-osteopontin signaling pathway. In summary, we used IMP2-deficient mice as a model to determine whether IMP2 plays a role during bone metabolism. Our results indicate that IMP2 deficiency delayed bone remodeling by significantly inhibiting the activity of osteoclasts and impairing their adhesion.


IMP2 Bone remodeling Osteoclast Adhesion 



We thank Liwen Bianji, Edanz Editing China (, for editing the English text of a draft of this manuscript.


This study was partially supported by the National Nature Science Foundation of China (Grant Nos 81470719, 81611140133) to M. Li, Shandong Provincial Natural Science Foundation (Grant No ZR201702180144) to H. Liu, China Postdoctoral Science Foundation (Grant No 2017M622220) to H. Liu, and the construction engineering special fund of “Taishan Scholars” (Grant No ts201511106) to X. Xu.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.


  1. Avnet S, Salerno M, Quacquaruccio G, Granchi D, Giunti A, Baldini N (2011) IGF2 derived from SH-SY5Y neuroblastoma cells induces the osteoclastogenesis of human monocytic precursors. Exp Cell Res 317:2147–2158. CrossRefPubMedGoogle Scholar
  2. Barghash A, Helms V, Kessler SM (2015) Overexpression of IGF2 mRNA-binding protein 2 (IMP2/p62) as a feature of basal-like breast cancer correlates with short survival. Scand J Immunol 82:142–143. CrossRefPubMedGoogle Scholar
  3. Barghash A, Golob-Schwarzl N, Helms V, Haybaeck J, Kessler SM (2016) Elevated expression of the IGF2 mRNA binding protein 2 (IGF2BP2/IMP2) is linked to short survival and metastasis in esophageal adenocarcinoma. Oncotarget 7:49743–49750. CrossRefPubMedPubMedCentralGoogle Scholar
  4. Bell JL, Wachter K, Muhleck B, Pazaitis N, Kohn M, Lederer M, Huttelmaier S (2013) Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression? Cell Mol Life Sci 70:2657–2675. CrossRefPubMedGoogle Scholar
  5. Boudoukha S, Cuvellier S, Polesskaya A (2010) Role of the RNA-binding protein IMP-2 in muscle cell motility. Mol Cell Biol 30:5710–5725. CrossRefPubMedPubMedCentralGoogle Scholar
  6. Chabadel A et al (2007) CD44 and beta3 integrin organize two functionally distinct actin-based domains in osteoclasts. Mol Biol Cell 18:4899–4910. CrossRefPubMedPubMedCentralGoogle Scholar
  7. Christiansen J, Kolte AM, Hansen T, Nielsen FC (2009) IGF2 mRNA-binding protein 2: biological function and putative role in type 2 diabetes. J Mol Endocrinol 43:187–195. CrossRefPubMedGoogle Scholar
  8. Dai N et al (2015) IGF2BP2/IMP2-deficient mice resist obesity through enhanced translation of Ucp1 mRNA and other mRNAs encoding mitochondrial proteins. Cell Metab 21:609–621. CrossRefPubMedPubMedCentralGoogle Scholar
  9. Dai N, Ji F, Wright J, Minichiello L, Sadreyev R, Avruch J (2017) IGF2 mRNA binding protein-2 is a tumor promoter that drives cancer proliferation through its client mRNAs IGF2 and HMGA1. Elife 6. Google Scholar
  10. Degrauwe N, Suva ML, Janiszewska M, Riggi N, Stamenkovic I (2016) IMPs: an RNA-binding protein family that provides a link between stem cell maintenance in normal development and cancer. Genes Dev 30:2459–2474. CrossRefPubMedPubMedCentralGoogle Scholar
  11. Edwards JR, Mundy GR (2011) Advances in osteoclast biology: old findings and new insights from mouse models. Nat Rev Rheumatol 7:235–243. CrossRefPubMedGoogle Scholar
  12. Hardouin SN, Guo R, Romeo PH, Nagy A, Aubin JE (2011) Impaired mesenchymal stem cell differentiation and osteoclastogenesis in mice deficient for Igf2-P2 transcripts. Development 138:203–213. CrossRefPubMedGoogle Scholar
  13. Janiszewska M et al (2012) Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells. Genes Dev 26:1926–1944. CrossRefPubMedPubMedCentralGoogle Scholar
  14. Kessler SM, Pokorny J, Zimmer V, Laggai S, Lammert F, Bohle RM, Kiemer AK (2013) IGF2 mRNA binding protein p62/IMP2–2 in hepatocellular carcinoma: antiapoptotic action is independent of IGF2/PI3K signaling. Am J Physiol Gastrointest Liver Physiol 304:G328-336. CrossRefGoogle Scholar
  15. Li M et al (2006) Histochemical evidence of osteoclastic degradation of extracellular matrix in osteolytic metastasis originating from human lung small carcinoma (SBC-5) cells. Microsc Res Tech 69:73–83. CrossRefPubMedGoogle Scholar
  16. Li M et al (2013) Histological examination on osteoblastic activities in the alveolar bone of transgenic mice with induced ablation of osteocytes. Histol Histopathol 28:327–335. PubMedGoogle Scholar
  17. Li Y, Francia G, Zhang JY (2015) p62/IMP2 stimulates cell migration and reduces cell adhesion in breast cancer. Oncotarget 6:32656–32668. PubMedPubMedCentralGoogle Scholar
  18. Liu X, Ye H, Li L, Li W, Zhang Y, Zhang JY (2014) Humoral autoimmune responses to insulin-like growth factor II mRNA-binding proteins IMP1 and p62/IMP2 in ovarian cancer. J Immunol Res 2014:326593. PubMedPubMedCentralGoogle Scholar
  19. Liu Y, Yu C, Wu Y, Sun X, Su Q, You C, Xin H (2017) CD44 + fibroblasts increases breast cancer cell survival and drug resistance via IGF2BP3-CD44-IGF2 signalling. J Cell Mol Med 21:1979–1988. CrossRefPubMedPubMedCentralGoogle Scholar
  20. Livingstone C, Borai A (2014) Insulin-like growth factor-II: its role in metabolic and endocrine disease. Clin Endocrinol (Oxf) 80:773–781. CrossRefGoogle Scholar
  21. Miyazaki T, Sanjay A, Neff L, Tanaka S, Horne WC, Baron R (2004) Src kinase activity is essential for osteoclast function. J Biol Chem 279:17660–17666. CrossRefPubMedGoogle Scholar
  22. Nakao K, Aoyama M, Fukuoka H, Fujita M, Miyazawa K, Asai K, Goto S (2009) IGF2 modulates the microenvironment for osteoclastogenesis. Biochem Biophys Res Commun 378:462–466. CrossRefPubMedGoogle Scholar
  23. Nakashima T, Takayanagi H (2011) New regulation mechanisms of osteoclast differentiation. Ann N Y Acad Sci 1240:E13–E18. CrossRefPubMedGoogle Scholar
  24. Nielsen J, Christiansen J, Lykke-Andersen J, Johnsen AH, Wewer UM, Nielsen FC (1999) A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol 19:1262–1270CrossRefPubMedPubMedCentralGoogle Scholar
  25. Sakiyama H, Inaba N, Toyoguchi T, Okada Y, Matsumoto M, Moriya H, Ohtsu H (1994) Immunolocalization of complement C1s and matrix metalloproteinase 9 (92 kDa gelatinase/type IV collagenase) in the primary ossification center of the human femur. Cell Tissue Res 277:239–245PubMedGoogle Scholar
  26. Saxena R et al (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316:1331–1336. CrossRefPubMedGoogle Scholar
  27. Schaeffer V, Hansen KM, Morris DR, LeBoeuf RC, Abrass CK (2012) RNA-binding protein IGF2BP2/IMP2 is required for laminin-beta2 mRNA translation and is modulated by glucose concentration. Am J Physiol Renal Physiol 303:F75–F82. CrossRefPubMedPubMedCentralGoogle Scholar
  28. Scott LJ et al (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316:1341–1345. CrossRefPubMedPubMedCentralGoogle Scholar
  29. Suzuki K, Zhu B, Rittling SR, Denhardt DT, Goldberg HA, McCulloch CA, Sodek J (2002) Colocalization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts. J Bone Miner Res 17:1486–1497. CrossRefPubMedGoogle Scholar
  30. Tsuboi K et al (2016) Effects of drug discontinuation after short-term daily alendronate administration on osteoblasts and osteocytes in mice. Histochem Cell Biol 146:337–350. CrossRefPubMedGoogle Scholar
  31. Wit JM, Camacho-Hubner C (2011) Endocrine regulation of longitudinal bone growth. Endocr Dev 21:30–41. CrossRefPubMedGoogle Scholar
  32. Yisraeli JK (2005) VICKZ proteins: a multi-talented family of regulatory RNA-binding proteins. Biol Cell 97:87–96. CrossRefPubMedGoogle Scholar
  33. Zhang JY, Chan EK, Peng XX, Tan EM (1999) A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma. J Exp Med 189:1101–1110CrossRefPubMedPubMedCentralGoogle Scholar
  34. Zhou SL et al (2014) Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma. Dis Esophagus 27:790–797. CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Shandong Provincial Key Laboratory of Oral Tissue Regeneration, Department of Bone MetabolismSchool of Stomatology Shandong UniversityJinanChina
  2. 2.Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical SciencesInstitute of Medicinal Chemistry, Shandong UniversityJinanChina

Personalised recommendations